A preliminary investigation of cognitive late effects and the impact of disease versus treatment among pediatric brain tumor patients

Children's Health Care

Volumn 36, Issue 4, 2007, Pages 373-384

  Taylor, Lloyd A ^a   Reeves, Cara ^b   McCart, Michael R ^b   Bushardt, Reamer L ^b   Jensen, Scott A ^c   Elkin, T David ^c   Borntrager, Cameo ^b   Brown, Ronald T ^d   Simpson, Kit ^b   Boll, Thomas ^e  

^a THE CITADEL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e Neuropsychology Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILD BEHAVIOR; CHILD CARE; CLINICAL ARTICLE; COGNITION; FEMALE; HUMAN; MALE; NEUROLOGIC EXAMINATION; RADIATION DOSE; RATING SCALE; SCORING SYSTEM; SURGICAL TECHNIQUE; TREATMENT PLANNING;

EID: 36849032879     PISSN: 02739615     EISSN: None     Source Type: Journal    
DOI: 10.1080/02739610701601395     Document Type: Article

References (20)

1. Beebe, D. W., Ris, M. D., Armstrong, F. D., Fontanesi, J., Mulhern, R., Holmes, E., et al. (2005). Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: Evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130). Journal of Clinical Oncology, 23, 5198-5204.
2. Cohen, J. (1992). A power primer. Psychological Bulletin, 112, 155-159.
3. Conners, C. K. (1997). Conners' Rating Scales-Revised User's Manual. North Tonawanda, NY: Multi-Health Systems, Inc.
4. Copeland, D. R., deMoor, C., Moore, B. D., & Ater, J. L. (1999). Neurocognitive development of children after a cerebellar tumor in infancy: A longitudinal study. Journal of Clinical Oncology, 17, 3476-3486.
5. Fouladi, M., Gilger, E., Kocak, M., Wallace, D., Buchanan, G., Reeves, C., et al. (2005). Intellectual and functional outcome of children ≤ 3 years of age with CNS malignancies. Journal of Clinical Oncology, 23, 7152-7160.
6. Levishon L., Cronin-Golomb A., & Schmahmann, J. D. (2000). Neuropsychological consequences of cerebellar tumour resection in children: Cerebellar cognitive affective syndrome in a pediatric population. Brain, 123, 1041-1050.
7. Meyer, E. A., & Kieran, M. W. (2002). Psychological adjustment of surgery-only pediatric neurooncology patients: A retrospective analysis. Psycho-Oncology, 11(1), 74-79.
8. Meyers, C. A., Weitzner, M. A., Valentine, A. D., & Levin, V. A. (1998). Methylphenidate therapy improves cognition, mood, and function in brain tumor patients. Journal of Clinical Oncology, 16, 2522-2527.
9. Mulhern, R. K. (1994). Neuropsychological late effects. In D. J. Bearsion & R. K. Mulhern (Eds.), Pediatric psychooncology: Psychological perspectives on children with cancer (pp. 99-121). New York: Oxford University Press.
10. Mulhern, R. K., Merchant, T. E., Gajjar, A., Reddick, W. E., & Kun, L. (2004). Late neurocognitive sequelae in survivors of brain tumors in childhood. Lancet, 5, 399-408.
11. Mulhern R. K., Palmer S. L., Reddick W. E., Glass J. O., Kun L. E., Taylor J., et al. (2001). Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. Journal of Clinical Oncology, 19, 472-479.
12. Palmer, S. L., Gajjar, A., Reddick, W. E., Glass, J. O., Kun, L., Wu, S., et al. (2003). Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma. Neuropsychology, 17, 548-555.
13. Palmer, S. L., Goloubeva, O., Reddick, W. E., Glass, J. O., Gajjar, A., Kun, L., et al. (2001). Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis. Journal of Clinical Oncology, 19, 2302-2308.
14. Reddick, W. E., White, H. A., Glass, J. O., Wheeler, G. C., Thompson, S. J., Gajjar, A., et al. (2003). Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer, 97, 2512-2519.
15. Ries, L. G., Smith, M. A., Gurney, J. G., Linet, M., Tamra, T., Young, J. L., et al. (1999). Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995 (Pub. No. 99-4649). Bethesda, MD: National Cancer Institute.
16. Silber, J. H., Radcliffe, J., Peckham, V., Perilongo, G., Kishnani, P., Fridman, M., et al. (1992). Whole-brain irradiation and decline in intelligence: The influence of dose and age on IQ score. Journal of Clinical Oncology, 10, 1390-1396.
17. Spiegler, B. J., Bouffet, E., Greenberg, M. L., Rufka, J. T., & Mabbott, D. J. (2004). Change in neurocognitive functioning after treatment with cranial radiation in childhood. Journal of Clinical Oncology, 22, 706-713.
18. Vanderploeg, R. D., Schinka, J. A., Baum, K. M., Tremont, G., & Mittenberg, W. (1998). WISC-III premorbid prediction strategies: Demographic and best performance approaches. Psychological Assessment, 10, 277-284.
19. Wechsler, D. (1991). Manual for the Wechsler Intelligence Scale for Childem. 3rd ed. San Antonio, TX: The Psychological Corporation.
20. Wechsler, D. (1999). Manual for the Wechsler Abbreviated Identification Scale (WASI). San Antonio, TX: The Psychological Corporation.